Zur Kurzanzeige

2011-12-27Zeitschriftenartikel DOI: 10.1155/2012/595427
Evaluating frequency, diagnostic quality, and cost of lyme borreliosis testing in Germany: a retrospective model analysis.
dc.contributor.authorMüller, I.
dc.contributor.authorFreitag, M. H.
dc.contributor.authorPoggensee, Gabriele
dc.contributor.authorScharnetzky, E.
dc.contributor.authorStraube, E.
dc.contributor.authorSchoerner, Ch.
dc.contributor.authorHlobil, H.
dc.contributor.authorHagedorn, Hans-Jochen
dc.contributor.authorStanek, G.
dc.contributor.authorSchubert-Unkmeir, A.
dc.contributor.authorNorris, D. E.
dc.contributor.authorGensichen, J.
dc.contributor.authorHunfeld, K.-P.
dc.date.accessioned2018-05-07T15:09:04Z
dc.date.available2018-05-07T15:09:04Z
dc.date.created2012-01-31
dc.date.issued2011-12-27none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/re3n01l8fzGj2/PDF/269UIqRGEez.pdf
dc.identifier.urihttp://edoc.rki.de/176904/1053
dc.description.abstractBackground: Data on the economic impact of Lyme borreliosis (LB) on European health care systems is scarce. This project focused on the epidemiology and costs for laboratory testing in LB patients in Germany. Materials and Methods: We performed a sentinel analysis of epidemiological and medicoeconomic data for 2007 and 2008. Data was provided by a German statutory health insurance (DAK) company covering approx. 6.04 million members. In addition, the quality of diagnostic testing for LB in Germany was studied. Results: In 2007 and 2008, the incident diagnosis LB was coded on average for 15,742 out of 6.04 million insured members (0.26%). 20,986 EIAs and 12,558 immunoblots were ordered annually for these patients. For all insured members in the outpatient sector, a total of 174,820 EIAs and 52,280 immunoblots were reimbursed annually to health care providers (cost: 2,600,850€). For Germany, the overall expected cost is estimated at 51,215,105€. However, proficiency testing data questioned test quality and standardization of diagnostic assays used. Conclusion: Findings from this study suggest ongoing issues related to care for LB and may help to improve future LB disease management.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionsepidemiologie
dc.subjectHumanseng
dc.subjectGermany/epidemiologyeng
dc.subjectPrevalenceeng
dc.subjectIncidenceeng
dc.subjectSensitivity and Specificityeng
dc.subjectRetrospective Studieseng
dc.subjectReproducibility of Resultseng
dc.subjectClinical Laboratory Techniques/standardseng
dc.subjectBorrelia/immunologyeng
dc.subjectClinical Laboratory Techniques/economicseng
dc.subjectHealth Care Costseng
dc.subjectInsurance Health/economicseng
dc.subjectLyme Disease/diagnosiseng
dc.subjectLyme Disease/economicseng
dc.subjectLyme Disease/epidemiologyeng
dc.subjectModels Statisticaleng
dc.subjectOutpatientseng
dc.subjectReagent Kits Diagnostic/standardseng
dc.subject.ddc610 Medizin
dc.titleEvaluating frequency, diagnostic quality, and cost of lyme borreliosis testing in Germany: a retrospective model analysis.
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10018088
dc.identifier.doi10.1155/2012/595427
dc.identifier.doihttp://dx.doi.org/10.25646/978
local.edoc.container-titleClinical and Developmental Immunology
local.edoc.container-textI. Müller, M. H. Freitag, G. Poggensee, et al., “Evaluating Frequency, Diagnostic Quality, and Cost of Lyme Borreliosis Testing in Germany: A Retrospective Model Analysis,” Clinical and Developmental Immunology, vol. 2012, Article ID 595427, 13 pages, 2012.
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.hindawi.com/journals/cdi/2012/595427/abs/
local.edoc.container-publisher-nameHindawi Publishing Corporation
local.edoc.container-year2011

Zur Kurzanzeige